Drug intelligence / Profile preview

Uristat Plus

Development stage
Preclinical
Lead developer
Novogen Captab
Modality
Small Molecules
Administration
Oral
01

Overview

Uristat Plus is a combination nutraceutical product developed by Novogen Captab, specifically formulated to support urinary tract health and prevent recurrent urinary tract infections (UTIs). The formulation contains Cranberry Extract (200 mg), Potassium Magnesium Citrate (978 mg), and D-Mannose (300 mg). D-Mannose and Cranberry proanthocyanidins act as anti-adhesion agents that bind to the fimbriae of pathogenic bacteria like *Escherichia coli*, preventing them from attaching to the bladder wall and facilitating their clearance through urination. Potassium Magnesium Citrate acts as a urinary alkalinizer, helping to maintain an optimal urinary pH and reducing the acidity that can contribute to bladder irritation and the formation of certain types of kidney stones.

Brand names
Uristat Plus
Other names
Cranberry Extract + Potassium Magnesium Citrate + D-Mannose
02

Targets

FimH (Type 1 fimbrial adhesin)UMOD (Uromodulin)PapG (PapG adhesin)

Beyond the preview

Go deeper on Uristat Plus.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Uristat Plus.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call